Skip to main content

Table 6 Summary of lymphocyte profile values at screening, 1 month & 6 month follow-up after BM-MSC implantation

From: A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia

Test Screening 1 month 6 months
BM-MSC arm Placebo BM-MSC arm Placebo BM-MSC arm Placebo
N = 10 N = 10 N = 9 N = 10 N = 7 N = 10
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
CD4 (cells/μl) 923.1 (217.52) 856.3 (237.29) 905.6 (134.37) 922.4 (451.48) 1020.9 (405.67) 954.4 (164.49)
CD8 (cells/μl) 682.5 (253.96) 688.3 (420.36) 664.2 (183.02) 644.9 (396.27) 786.3 (329.27) 727.9 (312.25)
CD25 (cells/μl) 21.3 (22.22) 16.3 (10.92) 21.7 (14.34) 22.0 (20.66) 30.3 (25.36) 35.3 (28.04)
\